Are patients with heart failure and chronic kidney disease less likely to be prescribed and adhere to guideline-recommended medical therapies?
There are significant gaps in the prescription, dispensation, and adherence to guideline-directed medical therapies among patients with concurrent heart failure and chronic kidney disease.
Patients with HF and CKD are less likely to be prescribed and to fill prescriptions for evidence-based therapies, showing lower adherence and persistence, even at eGFR categories where these therapies are recommended and have shown efficacy in clinical trials.
Janse et al. (Tue,) studied this question.